ARTICLE | Clinical News
Allervax Cat peptide immunotherapeutic: Began enrollment of 300 allergic patients in a Phase III trial
April 10, 1995 7:00 AM UTC
ImmuLogic Pharmaceutical Corp. (IMUL), Waltham, Mass. Product: Allervax Cat peptide immunotherapeutic Indication: Cat allergy Status: Began enrollment of 300 allergic patients in a Phase III trial ...